Please try another search
For the 39 weeks ended 27 September 2020, WrightMedical Group NV revenues decreased 15% to $571.9M. Netloss before extraordinary items decreased 5% to $81.5M.Revenues reflect International Extremities & Biologicssegment decrease of 28% to $114.7M, U.S. Lower Extremities& Biologics segment decrease of 15% to $228.9M, U.S. UpperExtremities segment decrease of 6% to $228.3M.
Period Ending: | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 |
---|---|---|---|---|
Total Revenue | 223.37 | 129.96 | 218.54 | 248.6 |
Gross Profit | 178.23 | 101.23 | 179.62 | 199.06 |
Operating Income | 16.36 | -39.28 | -2.69 | 14.12 |
Net Income | -19.72 | -59.39 | -14.91 | -16.02 |
Period Ending: | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 |
---|---|---|---|---|
Total Assets | 2598.72 | 2563.53 | 2480.58 | 2585.64 |
Total Liabilities | 1744.47 | 1722.6 | 1601.22 | 1693.85 |
Total Equity | 854.25 | 840.92 | 879.36 | 891.79 |
Period Ending: | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 10.4 | -10.94 | 19.33 | 41.61 |
Cash From Investing Activities | -56.32 | -42.91 | -26.63 | -103.25 |
Cash From Financing Activities | 19.98 | 20.71 | -55.82 | 37.41 |
Net Change in Cash | -25.31 | -33.2 | -64.02 | -24.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review